XGBAX:NMF-Guggenheim Build Amrc Bnds Mngd Drtn Trs (USD)

FUND | Others |

Last Closing

USD 15.89

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VRGWX Vanguard Russell 1000 Growth I..

+3.43 (+0.47%)

USD 26.28B
XMDYX Mid Cap SPDR 400 Trust Series ..

N/A

USD 19.32B
VRTIX Vanguard Russell 2000 Index Fu..

+8.21 (+2.51%)

USD 10.02B
VRVIX Vanguard Russell 1000 Value In..

+2.52 (+0.80%)

USD 9.85B
VRNIX Vanguard Scottsdale Funds - Va..

+3.08 (+0.63%)

USD 7.05B
VRTTX Vanguard Russell 3000 Index Fu..

+3.42 (+0.72%)

USD 3.51B
XAODX Alpine Total Dynamic Dividend ..

+0.06 (+0.60%)

USD 2.09B
XNUVX Nuveen Municipal Value Fd Inc

-0.03 (-0.32%)

USD 2.06B
VRTGX Vanguard Russell 2000 Growth I..

+9.19 (+2.45%)

USD 1.19B
XJPCX Nuveen Preferred Income Opport..

-0.04 (-0.49%)

USD 0.99B

ETFs Containing XGBAX

GAL SPDR® SSgA Global Alloca.. 19.38 % 0.09 %

+0.20 (+-0.18%)

USD 0.24B
HNDL Strategy Shares Nasdaq 7 .. 0.00 % 0.95 %

-0.04 (-0.18%)

USD 0.80B

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.75% 4% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.75% 4% F 4% F
Trailing 12 Months  
Capital Gain 2.71% 14% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.71% 14% F 14% F
Trailing 5 Years  
Capital Gain -32.06% 2% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.06% 2% F 2% F
Average Annual (5 Year Horizon)  
Capital Gain -7.12% N/A N/A 2% F
Dividend Return -7.12% N/A N/A 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 49.47% N/A N/A 4% F
Risk Adjusted Return -14.38% N/A N/A 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike